Geng, US
Bolin Geng, Waltham, MA US
Patent application number | Description | Published |
---|---|---|
20100144717 | 2-QUINOLINONE AND 2-QUINOXALINONE-DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS - The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation. | 06-10-2010 |
20100152441 | COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS - The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. In particular this invention relates to compounds useful for the treatment of bacterial infections in warm-blooded animals such as humans, more particularly to the use of these compounds in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. | 06-17-2010 |
20110092495 | COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS - The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. In particular this invention relates to compounds useful for the treatment of bacterial infections in warm-blooded animals such as humans, more particularly to the use of these compounds in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. | 04-21-2011 |
20110288084 | [4-( 1-AMINO-ETHYL) - CYCLOHEXYL ] - METHYL - AMINES AS ANTIBACTERIALS - The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation. | 11-24-2011 |
20120108577 | COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS - The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. In particular this invention relates to compounds useful for the treatment of bacterial infections in warm-blooded animals such as humans, more particularly to the use of these compounds in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. | 05-03-2012 |
20120270864 | 2-QUINOLINONE AND 2-QUINOXALINONE-DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS - The present invention relates to compounds of Formula (I): | 10-25-2012 |
20150073011 | Beta-Lactamase Inhibitor Compounds - The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia): | 03-12-2015 |
Chaoxian Geng, Westford, MA US
Patent application number | Description | Published |
---|---|---|
20100212029 | NOVEL ASSAYS UTILIZING NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNITS - The present invention is in the field of identification and characterization of novel insecticidal target sites and, in particular, relates to host cells, assays and antibodies thereto. | 08-19-2010 |
Chaoxian Geng, Zionsville, IN US
Patent application number | Description | Published |
---|---|---|
20120174258 | NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 07-05-2012 |
20120174259 | NUCLEIC ACID MOLECULES THAT TARGET THE VACUOLAR ATPASE C SUBUNIT AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 07-05-2012 |
20120174260 | NUCLEIC ACID MOLECULES THAT TARGET THE RHO1 SMALL GTP-BINDING PROTEIN AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 07-05-2012 |
20120198586 | NUCLEIC ACID MOLECULES THAT TARGET THE VACUOLAR ATPASE H SUBUNIT AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 08-02-2012 |
20130091600 | NUCLEIC ACID MOLECULES THAT TARGET PP1-87B AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 04-11-2013 |
20130091601 | NUCLEIC ACID MOLECULES THAT TARGET RPA70 AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 04-11-2013 |
20130097730 | NUCLEIC ACID MOLECULES THAT TARGET RPS6 AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 04-18-2013 |
20140298536 | NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 10-02-2014 |
20150176025 | RAS OPPOSITE (ROP) AND RELATED NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND/OR HEMIPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran and/or hemipteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran and/or hemipteran pests. The disclosure also concerns methods for making that express nucleic acid molecules useful for the control of coleopteran and/or hemipteran pests, and the plant cells and plants obtained thereby. | 06-25-2015 |
20150232859 | NUCLEIC ACID MOLECULES THAT TARGET THE VACUOLAR ATPASE C SUBUNIT AND CONFER RESISTANCE TO COLEOPTERAN PESTS - This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby. | 08-20-2015 |
Feng Geng, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20130072554 | Novel Method For Delivery and Use of Isothiocyanates For Prophylaxis and/or Therapy of Bladder Cancer - Provided is a composition that contains a mixture of broccoli seed and mustard seed. Before mixing the broccoli seed with the mustard seed, the broccoli seed is subjected to baking and a pressurized heat treatment. The broccoli seed is baked at a temperature of at least 200 degrees Fahrenheit for at least 60 minutes, and is subjected to a pressurized heat treatment of at least 200 degrees Fahrenheit at a pressure of at least 10 pounds/square inch for at least 5 minutes. Also provided is a method for therapy and/or prophylaxis of bladder cancer in an individual. The method entails administering orally to the individual a composition that contains an isothiocyanate (ITC) or a derivative thereof such that the administration inhibits the growth and/or recurrence of bladder cancer. Nutraceutical compositions are also provided. | 03-21-2013 |
Feng Geng, Piscataway, NJ US
Patent application number | Description | Published |
---|---|---|
20100145107 | NOVEL PROPANOL AND RELATED COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS - The present invention a method of improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of a compound of formula: | 06-10-2010 |
20110286964 | AZO-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 11-24-2011 |
20110286965 | ETHENYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (A): (Chemical formula should be inserted here as it appears on abstract in paper form) (A) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein wherein each of R, R | 11-24-2011 |
20110318305 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 12-29-2011 |
20120041214 | HEXAHYDRO ETHANOCHROMENES AND RELATED COMPOUNDS AND THEIR USE IN FRAGRANCE COMPOSITIONS - The present invention relates to novel compounds and their use in fragrance compositions. Novel hexahydro ethanochromene and related hexahydro ethanochromane compounds of the present invention are represented by formula: | 02-16-2012 |
20120107271 | ETHYNYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R | 05-03-2012 |
20140329733 | PERFUME SYSTEMS - The present application relates to perfume delivery systems and consumer products comprising perfume delivery systems and or perfume raw materials, as well as processes for making and using such perfume delivery systems and consumer products. | 11-06-2014 |
20150111810 | 3-METHYL-BENZOFURAN-5-OL AND ITS USE IN PERFUME COMPOSITIONS - The present invention is directed to a novel fragrance compound, 3-methyl-benzofuran-5-ol, and a method of improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of 3-methyl-benzofuran-5-ol. | 04-23-2015 |
Haifeng Geng, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100035960 | BIOSYNTHETIC PATHWAY AND GENES REQUIRED FOR TROPODITHIETIC ACID BIOSYNTHESIS IN SILICIBACTER TM1040 - Production and use of a sulfur-containing compound, tropodithietic acid (TDA), from the | 02-11-2010 |
Hao Geng, Aston, PA US
Patent application number | Description | Published |
---|---|---|
20140200227 | THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases. | 07-17-2014 |
Huaizhi Geng, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20090078914 | Methods and devices for electrophoretic deposition of a uniform carbon nanotube composite film - Methods and devices are provided relating to the homogeneous deposition of a composite film of carbon nanotubes by electrophoresis. The methods comprise linking carbon nanotubes to matrix particles prior to electrophoretic deposition. The methods improve the adhesion of the composite film to the substrate and reduce the surface roughness. Carbon nanotube films and electron field emission cathodes fabricated by this process demonstrate enhanced electron field emission characteristics. | 03-26-2009 |
Jian-Guo Geng, Saline, MI US
Patent application number | Description | Published |
---|---|---|
20160000865 | COMPOSITIONS AND METHODS RELATING TO INDUCTION OF INTESTINAL STEM CELL HOMEOGENESIS AND/OR REGENERATION - The present invention relates to compositions and methods for inducing intestinal stem cell homeogenesis and/or regeneration within intestinal tissue expressing Robo1 through administration of a Rspo1 agent and a Slit2 agent. Administration of such agents results in, for example, binding of the Rspo1 agent and Slit2 agent with Robo1, resulting in, for example, binding of the CC3 motif of Robo1 with LRP6, resulting in phosphorylation of LRP6, and ultimately, induction of intestinal stem cell homeogenesis and/or regeneration. In certain embodiments, such administration of a Rspo1 agent and a Slit2 agent is used to protect and/or prevent intestinal tissue damage resulting from exposure to an intestinal tissue damaging event (e.g., radiation). The agents and related compositions additionally find use in diagnostic and research settings. | 01-07-2016 |
Jihong Geng, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20110019700 | MODE-LOCKED TWO MICRON FIBER LASERS - A mode-locked fiber laser comprising a multicomponent glass fiber doped with a trivalent rare-earth ion of thulium and/or holmium. | 01-27-2011 |
20110222562 | Mode-Locked Two-Micron Fiber Lasers - A mode-locked fiber laser comprising a multicomponent glass fiber doped with a trivalent rare-earth ion of thulium and/or holmium and including a fiber-optic based passive saturable absorber that contains an adhesive material mixed with a saturable absorbing components and is disposed along the length of an optical fiber such as to assure that a mode propagating within the fiber spatially overlaps with the volume occupied by the saturable absorbing components. | 09-15-2011 |
20110261454 | All-Fiber Optical Isolator - An all-fiber Faraday rotator including a plurality of optical fibers doped, at unusually high concentrations of at least several tens of percent, with rare-earth oxides, an all-optical-fiber optical isolator employing a polarization-maintaining fiber-optic splitter, and a method of optically-isolating a laser source from unwanted feedback with such an optical isolator. In a case where the doping concentration exceeds 55 weight-%, the length of the Faraday rotator achieving a 45-degree rotation of the polarization vector of light guided by an optical fiber does not exceed approximately 10 cm. | 10-27-2011 |
20130129272 | Faraday Rotator and Isolator - An all-fiber optic Faraday rotator and isolator is presented. The device has a multicomponent glass optical fiber having a core having a first doping concentration of 55%-85% (wt./wt.) of a first rare-earth oxide and a cladding having a section doping concentration of 55%-85% (wt./wt.) of a second rare-earth oxide, where the first rare-earth oxide and the second rare earth oxide are one or more of Pr | 05-23-2013 |
20140336626 | MEDICAL ASSEMBLY USING SHORT PULSE FIBER LASER - A method of ablating a solid substance within a mammalian body is presented. The method includes generating a superheated zone within the body using a fiber lasing assembly that emits pulses at a pulse repetition rate of 1 kHz to 500 kHz, where each pulse has a wavelength from 1.7 micron to 2.2 micron, a pulse width from 2 ns to 800 ns, and a pulse energy from 0.05 mJ to 2 mJ. The fiber lasing assembly used further includes a seed laser and an amplifier optically connected to the seed laser by an Ho-doped, Tm-doped, or Ho Tm co-doped fiber. | 11-13-2014 |
20150121962 | Laser Processing System Using Broad Band Pulsed Lasers - A laser material processing system which includes a pulsed fiber laser source having a continuous wavelength bandwidth of larger than 100 nm and pulse width of from 100 femtosecond to 1 microsecond, a broad band laser emitted from one core of an optical fiber, where the broad band laser is applied to a subject material to produce removal of the subject material and/or color change of the subject material. | 05-07-2015 |
Jinming Geng, Scarborough, ME US
Patent application number | Description | Published |
---|---|---|
20090286229 | Methods, Devices, Kits and Compositions for Detecting Roundworm - Methods, devices, kits and compositions for detecting the presence or absence of roundworm in a fecal sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, whipworm, and heartworm. Confirmation of the presence or absence of roundworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 11-19-2009 |
20090286231 | Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm - Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm, whipworm and/or hookworm in a fecal sample from a mammal and may also be able to distinguish between one or more helminth infections. Confirmation of the presence or absence of roundworm, whipworm and/or hookworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 11-19-2009 |
20100151500 | Compositions, Devices, Kits and Methods for Detecting Hookworm - Methods, devices, kits and compositions for detecting the presence or absence of hookworm in a fecal sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of hookworm in a fecal sample from a mammal that may also be infected with one or more of roundworm, whipworm, and heartworm. Confirmation of the presence or absence of hookworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 06-17-2010 |
20110086340 | METHODS, DEVICES, KITS AND COMPOSITIONS FOR DETECTING ROUNDWORM - Methods, devices, kits and compositions for detecting the presence or absence of roundworm in a mammalian sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, whipworm, and heartworm. Confirmation of the presence or absence of roundworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 04-14-2011 |
20130149694 | METHODS, DEVICES, KITS AND COMPOSITIONS FOR DETECTING ROUNDWORM, WHIPWORM, AND HOOKWORM - Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm, whipworm and/or hookworm in a fecal sample from a mammal and may also be able to distinguish between one or more helminth infections. Confirmation of the presence or absence of roundworm, whipworm and/or hookworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 06-13-2013 |
20130224759 | METHODS, DEVICES, KITS AND COMPOSITIONS FOR DETECTING ROUNDWORM - Methods, devices, kits and compositions for detecting the presence or absence of roundworm in a mammalian sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, whipworm, and heartworm. Confirmation of the presence or absence of roundworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 08-29-2013 |
20140170684 | Methods, Devices, Kits and Compositions for Detecting Roundworm - Methods, devices, kits and compositions for detecting the presence or absence of roundworm in a fecal sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, whipworm, and heartworm. Confirmation of the presence or absence of roundworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 06-19-2014 |
20140205994 | Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm - Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm, whipworm and/or hookworm in a fecal sample from a mammal and may also be able to distinguish between one or more helminth infections. Confirmation of the presence or absence of roundworm, whipworm and/or hookworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 07-24-2014 |
20150260718 | Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm - Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm, whipworm and/or hookworm in a fecal sample from a mammal and may also be able to distinguish between one or more helminth infections. Confirmation of the presence or absence of roundworm, whipworm and/or hookworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated. | 09-17-2015 |
Kebin Geng, Rocky River, OH US
Patent application number | Description | Published |
---|---|---|
20100292492 | CATALYSTS FOR ESTERIFICATION OF EPOXIDIZED SOYATES AND METHODS OF USING SAME - A combination of catalysts is disclosed as useful to promote the transesterification reaction of an epoxidized soyate with a polyol to yield a high percentage of epoxidized soyate diester with epoxy functionality retained. The primary catalyst is a metallic hydroxide, and the secondary catalyst is a titanate. Bioderived plasticizers useful for thermoplastics and thermosets result. | 11-18-2010 |
20100324185 | EPOXIDIZED SOYATE DIESTERS AND METHODS OF USING SAME - An unhindered polyol is used to react with an epoxidized soyate to make epoxidized soyate diester in the presence of a catalyst. The unhindered polyol can be 1,3-propanediol or any polyol having four or more carbon atoms with no two adjacent carbon atoms having hydroxyl functionality. Preferably, a combination of catalysts is used to promote the transesterification reaction of the epoxidized soyate with the unhindered polyol to yield a high percentage of epoxidized soyate diester with epoxy functionality retained. The primary catalyst is a metallic hydroxide, and the secondary catalyst is a titanate. Bioderived epoxidized soyate diester plasticizers useful for thermoplastics and thermosets result. | 12-23-2010 |
Kebin Geng, Solon, OH US
Patent application number | Description | Published |
---|---|---|
20140175338 | ELECTRICALLY CONDUCTIVE POLYPHENYLENE SULFIDE COMPOUNDS - An electrically conductive polymer compound is disclosed. The compound comprises a matrix comprising polyphenylene sulfide and carbon nanotubes and glass fibers dispersed in the matrix. The carbon nanotubes are disaggregated and disagglomerated within the polyphenylene sulfide, when the compound is viewed at 20,000× magnification. The compound is useful for making extruded or molded plastic articles that need electrical properties. | 06-26-2014 |
20150111986 | POLYOLEFIN INTUMESCENT PHOSPHOROUS FLAME RETARDANT SYSTEM - A flame retardant polypropylene compound is disclosed. The compound comprises a polypropylene and non-halogenated ammonium phosphate flame retardant, along with ethylene vinyl acetate, magnesium hydroxide; fluoroelastomer and other functional additives. The compound can achieve a UL 94 rating of V-0 at a thickness of 1.55 mm or greater. | 04-23-2015 |
Leo Geng, Holliday, UT US
Patent application number | Description | Published |
---|---|---|
20090273940 | LED lighting device - The present invention is a light generation device utilizing higher efficiency LED's while also allowing for interface with current lighting interfaces. The LED's are replaceable in the unit and may be interchanged with other LED's to affect lighting mood and style or simply for replacement in the event an LED ceases to function. | 11-05-2009 |
Lifeng Geng, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20090163493 | Benzene, Pyridine, and Pyridazine Derivatives - Disclosed are compounds and pharmaceutically acceptable salts of Formula I | 06-25-2009 |
20110034529 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES - Disclosed are compounds and pharmaceutically acceptable salts of Formula I | 02-10-2011 |
20110183977 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES - Disclosed are compounds and pharmaceutically acceptable salts of Formula I | 07-28-2011 |
20130137686 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES - Disclosed are compounds and pharmaceutically acceptable salts of Formula I | 05-30-2013 |
Lifeng Geng, Midlothian, VA US
Patent application number | Description | Published |
---|---|---|
20140343037 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES - Disclosed are compounds and pharmaceutically acceptable salts of Formula I | 11-20-2014 |
Lijian Geng, Holliday, UT US
Patent application number | Description | Published |
---|---|---|
20100187964 | LED Lighting Device - The present invention is a light generation device utilizing higher efficiency LED's while also allowing for interface with current lighting interfaces. The LED's are replaceable in the unit and may be interchanged with other LED's to affect lighting mood and style or simply for replacement in the event an LED ceases to function. | 07-29-2010 |
Linda Geng, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20130288976 | Methods for Determining the Presence or Risk of Developing Facioscapulohumeral Dystrophy (FSHD) - In one aspect, the invention provides a method of screening a human subject to determine if said subject has a genetic predisposition to develop, or is suffering from Facioscapulohumeral Dystrophy (FSHD), said method comprising: (a) providing a biological sample comprising genomic DNA from the subject; and (b) analyzing the portion of the genomic DNA in the sample corresponding to the distal D4Z4-pLAM region on chromosome 4 and determining the presence or absence of a polymorphism resulting in a functional polyadenylation sequence operationally linked to exon 3 of the DUX4 gene, wherein a determination of the absence of a functional polyadenylation sequence operationally linked to exon 3 of the DUX4 gene indicates that the subject does not have a genetic predisposition to develop, and is not suffering from FSHD, and/or wherein a determination of the presence of a functional polyadenylation sequence operationally linked to exon 3 of the DUX4 gene indicates that the subject has a genetic predisposition to develop, or is suffering from Facioscapulohumeral Dystrophy (FSHD). | 10-31-2013 |
Linda Geng, Plano, TX US
Patent application number | Description | Published |
---|---|---|
20140242093 | METHODS AND COMPOSITIONS FOR MODULATING THE INNATE IMMUNE RESPONSE AND/OR MYOGENESIS IN A MAMMALIAN SUBJECT - In one aspect, the present invention relates to methods for increasing, decreasing or maintaining the innate immune response in a mammalian subject comprising modulating the expression of DUX4-fl, or modulating the expression of beta-defensin 3 (DEFB103). In another aspect, the present invention relates to methods for increasing, decreasing or maintaining myogenesis or muscle differentiation in a mammalian subject comprising modulating the expression of beta-defensin 3 (DEFB103). In additional aspects, the present invention involves diagnostic methods based on assessment of identified biomarkers. | 08-28-2014 |
Liping Geng, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20100233725 | IMMUNOASSAYS EMPLOYING NON-PARTICULATE CHEMILUMINESCENT REAGENT - Methods and reagents are disclosed for conducting assays. Embodiments of the present methods and reagents are concerned with chemiluminescent reagents for determining the presence and/or amount of an analyte in a sample suspected of containing the analyte. The reagent is non-particulate and comprises a binding partner for the analyte and a chemiluminescent composition comprising an olefinic compound and a metal chelate. In embodiments of an assay, a combination is provided that comprises a sample suspected of containing the analyte, a chemiluminescent reagent as described above and a sensitizer reagent capable of generating singlet oxygen. The combination is subjected to conditions for binding of the analyte to the binding partner for the analyte. The sensitizer is activated and the amount of luminescence generated by the chemiluminescent composition is detected wherein the amount of luminescence is related to the amount of the analyte in the sample. | 09-16-2010 |
20140356885 | Reducing Non-Specifically Bound Molecules on Supports - Methods and reagents are disclosed for preparing a support for reaction of the support with an assay molecule. In the method the support is treated with a detergent at a concentration of about 0.01% to about 5% (by weight) at a temperature of about 4° C. to about 50° C. for a period of about 1 hour to about 24 hours and subsequently the support is washed. The support is contacted with the assay molecule under conditions for covalently binding the assay molecule to the support to form a conjugate of the support and the assay molecule. | 12-04-2014 |
20150072438 | COMPOUNDS AND METHODS FOR PREPARATION OF CONJUGATE REAGENTS - Compositions are disclosed that include a support having on a surface thereof at least an inner polysaccharide layer and an outer polysaccharide layer. The outer polysaccharide layer has pendant moieties each comprising a terminal amine functionality. The point of linkage of the pendant moiety to the outer polysaccharide layer does not comprise an amide bond. The composition may be employed in a method of conjugating a member of a specific binding pair to a particle. The method comprises reacting the terminal amine functionality of the composition with the member of the specific binding pair, which comprises an amine-reactive functionality. | 03-12-2015 |
Lisa Geng, Stuart, FL US
Patent application number | Description | Published |
---|---|---|
20130330428 | METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS - Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed. | 12-12-2013 |
Mao Geng, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20160139952 | Throttle Control on Cloud-based Computing Tasks - Systems and methods for throttle control on cloud-based computing tasks are provided. An example method includes, obtaining a service request from a first user, in a plurality of users, of the computer system; in accordance with a first determination that placing the service request in a service queue associated with the first user would not cause an enqueue counter associated with the first user to be exceeded, causing the service request to be placed in the service quest to await execution. The method also includes, after the service request is placed in the service queue, in accordance with a second determination that executing the service request would not cause a dequeue counter associated with the first user to be exceeded, causing the service request to be executed. | 05-19-2016 |
Mei Geng, Bedford, MA US
Patent application number | Description | Published |
---|---|---|
20090221035 | SYSTEMS AND METHODS FOR PROTEIN PRODUCTION - The invention relates to systems and methods for producing proteins of interest. The invention employs genetically-engineered animal or plant cells that have modified protein folding or processing capacities. In one aspect, the invention features genetically-engineered cells comprising one or more recombinant expression cassettes which encode (1) a protein of interest and (2) a polypeptide that is functional in the unfolded protein response (UPR) pathway of the cells. Co-expression of the polypeptide significantly increases the yield of the protein of interest in the genetically-engineered cells. In one example, the genetically-engineered cells are animal cells, and the co-expressed polypeptide is a component or modulator of an XB1- or ATF6-mediated UPR pathway. | 09-03-2009 |
20120322104 | SYSTEMS AND METHODS FOR PROTEIN PRODUCTION - The invention relates to systems and methods for producing proteins of interest. The invention employs genetically-engineered animal or plant cells that have modified protein folding or processing capacities. In one aspect, the invention features genetically-engineered cells comprising one or more recombinant expression cassettes which encode (1) a protein of interest and (2) a polypeptide that is functional in the unfolded protein response (UPR) pathway of the cells. Co-expression of the polypeptide significantly increases the yield of the protein of interest in the genetically-engineered cells. In one example, the genetically-engineered cells are animal cells, and the co-expressed polypeptide is a component or modulator of an XBP1- or ATF6-mediated UPR pathway. | 12-20-2012 |
Mingming Geng, Middleton, WI US
Patent application number | Description | Published |
---|---|---|
20140199591 | PASTED NICKEL HYDROXIDE ELECTRODE AND ADDITIVES FOR RECHARGEABLE ALKALINE BATTERIES - A pasted positive nickel hydroxide electrode for use in battery cells (e.g., in nickel zinc cells, and nickel metal hydride cells) includes nickel hydroxide particles, a cobalt metal and/or cobalt compound and a sulfur-containing complexing agent capable of forming a complex with cobalt. The presence of the sulfur-containing complexing agent, such as dialkyldithiocarbamate (e.g., sodium diethyldithiocarbamate) improves lifetime and capacity utilization of the nickel electrode. The resulting pasted nickel hydroxide electrode includes a CoOOH conductive matrix after formation. The surface of the nickel hydroxide particles in the electrode is modified in some embodiments by providing a cobalt-containing coating onto the surface of the nickel hydroxide particles, followed by oxidation with a strong oxidizing agent. The complexing agent can be added before, after, or during the oxidation. | 07-17-2014 |
Mingming Geng, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090202904 | PASTED NICKEL HYDROXIDE ELECTRODE FOR RECHARGEABLE NICKEL-ZINC BATTERIES - Active material for a positive electrode of a rechargeable alkaline electrochemical cell is made with nickel hydroxide particles or cobalt-coated nickel hydroxide particles treated with strongly oxidizing reagents such as alkali metal persulfate in alkaline solution. The active material also may be made with cobalt-coated nickel hydroxide particles having a high percentage of cobalt(III) on a surface or an average cobalt oxidation state of about 3 measured across the particles. The treated nickel hydroxide or cobalt-coated nickel hydroxide decreases the cobalt solubility in the alkaline electrolyte and increases the high-rate charge and discharge capability. The lower cobalt solubility decreases cobalt migration that can increase self discharge and lead to premature failure. | 08-13-2009 |
20090208839 | NICKEL HYDROXIDE ELECTRODE FOR RECHARGEABLE BATTERIES - The nickel hydroxide particles for a nickel hydroxide electrode may be treated using an alkaline solution of a strong oxidizing agent such as sodium or potassium persulfate to modify the surface nickel hydroxide structure. The resulting modified surface structure has been found to impart various benefits to electrodes formed from the nickel hydroxide. It is believed that the oxidation of cobalt compounds at the surface of the nickel hydroxide particles results in a highly conductive cobalt compound that plays an important role in the high reliability, high stability and high capacity utilization of nickel electrodes as described herein. | 08-20-2009 |
20120018669 | PASTED NICKEL HYDROXIDE ELECTRODE FOR RECHARGEABLE NICKEL-ZINC BATTERIES - Active material for a positive electrode of a rechargeable alkaline electrochemical cell is made with nickel hydroxide particles or cobalt-coated nickel hydroxide particles treated with strongly oxidizing reagents such as alkali metal persulfate in alkaline solution. The active material also may be made with cobalt-coated nickel hydroxide particles having a high percentage of cobalt(III) on a surface or an average cobalt oxidation state of about 3 measured across the particles. The treated nickel hydroxide or cobalt-coated nickel hydroxide decreases the cobalt solubility in the alkaline electrolyte and increases the high-rate charge and discharge capability. The lower cobalt solubility decreases cobalt migration that can increase self discharge and lead to premature failure. | 01-26-2012 |
20120018670 | NICKEL HYDROXIDE ELECTRODE FOR RECHARGEABLE BATTERIES - The nickel hydroxide particles for a nickel hydroxide electrode may be treated using an alkaline solution of a strong oxidizing agent such as sodium or potassium persulfate to modify the surface nickel hydroxide structure. The resulting modified surface structure has been found to impart various benefits to electrodes formed from the nickel hydroxide. It is believed that the oxidation of cobalt compounds at the surface of the nickel hydroxide particles results in a highly conductive cobalt compound that plays an important role in the high reliability, high stability and high capacity utilization of nickel electrodes as described herein. | 01-26-2012 |
Nieyan Geng, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140162620 | METHODS AND APPARATUS FOR UPDATING A DEVICE CONFIGURATION - Methods and apparatus are provided for device configuration (e.g., feature segment loading and system selection). Certain aspects of the present disclosure generally relate to operating a user equipment (UE) in a first radio access network (RAN) with a first set of modem features that supports the first RAN, detecting a second RAN not supported by the first set of modem features, and rebooting the modem software to load a second set of modem features that supports the detected RAN. For certain aspects, the first RAN may be a Time Division-Synchronous Code Division Multiple Access (TD-SCDMA) network and the second RAN may be a Wideband-Code Division Multiple Access (W-CDMA) network or Long-Term Evolution (LTE) network. This allows features to be loaded into memory (e.g., only) when they are required to support a detected RAN, rather than loading an entire image, thereby conserving DRAM and increasing efficiency. | 06-12-2014 |
20160124659 | Efficient Decompression Locality System for Demand Paging - Aspects include computing devices, systems, and methods for implementing executing decompression of a compressed page. A computing device may determine a decompression block belonging to a compressed page that contains a code instruction requested in a memory access request. Decompression blocks, other than the decompression block containing the requested code instruction, may be selected for decompression based on their locality with respect to the decompression block containing the requested code instruction. Decompression blocks not identified for decompression may be substituted for a fault or exception code. The computing device may decompress decompression blocks identified for decompression, terminating the decompression of the compressed page upon filling all blocks with decompressed blocks, faults, or exception code. The remaining decompression blocks belonging to the compressed page may be decompressed after or concurrently with the execution of the requested code instruction. | 05-05-2016 |
20160124867 | Reducing Decompression Time Without Impacting Compression Ratio - Aspects include computing devices, systems, and methods for implementing executing decompression of a compressed page. A computing device may determine a decompression block of a compressed page that contains a code instruction requested in a memory access request. Decompression blocks, other than the decompression block containing the requested code instruction, may be selected for decompression based on being situated between an end of the compressed page and the decompression block containing the requested code instruction. Decompression blocks not identified for decompression may be substituted for a fault or exception code. The computing device may decompress decompression blocks identified for decompression, starting at the end of the compressed page and terminating the decompression of the compressed page upon filling all blocks with decompressed blocks, faults, or exception code. The remaining decompression blocks of the compressed page may be decompressed after or concurrently with the execution of the requested code instruction. | 05-05-2016 |
Peng Geng, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20090043107 | Process for Synthesizing Compounds Useful for Treating Hepatitis C - The present disclosure generally relates to a process for synthesizing methyl ((1S)-1-(((2S)-2-(5-(4′-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3- methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt. The present disclosure also generally relates to intermediates useful in this process. | 02-12-2009 |
Penghe Geng, Vernon, CT US
Patent application number | Description | Published |
---|---|---|
20140354430 | ENERGY HARVESTING, AMBIENT LIGHT FLUCTUATION SENSING INTRUSION DETECTOR - Embodiments are directed to detecting that an intrusion is occurring by detecting, by a first sensor, that the intrusion is occurring based on a variation of light exceeding a threshold, detecting, by a second sensor, that the intrusion is occurring, and generating an intrusion status signal that indicates the intrusion is occurring based on determining that the first and second sensors detect that the intrusion is occurring. | 12-04-2014 |
20150208042 | SYSTEM AND METHOD FOR AUTO-COMMISSIONING AN INTELLIGENT VIDEO SYSTEM - An auto-commissioning system provides automatic parameter selection for an intelligent video system based on target video provided by the intelligent video system. The auto-commissioning system extracts visual feature descriptors from the target video and provides the one or more visual feature descriptors associated with the received target video to an parameter database that is comprised of a plurality of entries, each entry including a set of one or more stored visual feature descriptors and associated parameters tailored for the set of stored visual feature descriptors. A search of the parameter database locates one or more best matches between the extracted visual feature descriptors and the stored visual feature descriptors. The parameters associated with the best matches are returned as part of the search and used to commission the intelligent video system. | 07-23-2015 |
20160065824 | HIGH DYNAMIC RANGE IMAGE SENSOR - An image processing system has a sensor array with a plurality of pixels. A distinct circuit is associated with each pixel in the sensor array. The circuits are designed such that across the plurality of circuits, there are a plurality of distinct sensitivities to irradiance from a scene to be captured which are spatially pseudo-randomly ordered relative to each other. The image processing system also comprises an image reconstruction algorithm. A method is also disclosed. | 03-03-2016 |
Penghe Geng, East Hartford, CT US
Patent application number | Description | Published |
---|---|---|
20130002863 | SYSTEM AND METHOD FOR AUTO-COMMISSIONING AN INTELLIGENT VIDEO SYSTEM - An auto-commissioning system provides automatic parameter selection for an intelligent video system based on target video provided by the intelligent video system. The auto-commissioning system extracts visual feature descriptors from the target video and provides the one or more visual feature descriptors associated with the received target video to an parameter database that is comprised of a plurality of entries, each entry including a set of one or more stored visual feature descriptors and associated parameters tailored for the set of stored visual feature descriptors. A search of the parameter database locates one or more best matches between the extracted visual feature descriptors and the stored visual feature descriptors. The parameters associated with the best matches are returned as part of the search and used to commission the intelligent video system. | 01-03-2013 |
Quan Geng, Urbana, IL US
Patent application number | Description | Published |
---|---|---|
20130272443 | METHODS AND APPARATUS TO IMPROVE CHANNEL ESTIMATION IN COMMUNICATION SYSTEMS - A method, an apparatus, and a computer program product for wireless communication are provided. The apparatus generates a codeword, determines at least one puncture to the codeword based on allowing a legacy receiver to decode the codeword without knowledge of the at least one puncture, replaces each of the at least one puncture with a pilot, and transmits the codeword. The apparatus may also generate an IEEE 802.11 codeword having pilots in a first set of subcarriers, and puncture the codeword with additional pilots unknown to a legacy receiver in a second set of subcarriers. Accordingly, when an original set of pilot symbols is insufficient or inappropriately placed in a resource structure, a codeword may be transmitted with a new pilot structure capable of being decoded by legacy receivers not aware of the new pilot structure. | 10-17-2013 |
Shuo Geng, Toledo, OH US
Patent application number | Description | Published |
---|---|---|
20120015040 | Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof - Dendritic cell precursor populations, dendritic cell populations derived therefrom, methods for isolating, expanding and using are disclosed. | 01-19-2012 |
20150126398 | Methods for Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom, and Uses Thereof - Dendritic cell precursor populations, dendritic cell populations derived therefrom, methods for isolating, expanding and using are disclosed. | 05-07-2015 |
Steven M. Geng, Parma, OH US
Patent application number | Description | Published |
---|---|---|
20110175369 | Apparatus and methods for mitigating electromagnetic emissions - Apparatus, methods, and other embodiments associated with mitigation of magnetic fields are described herein. In an embodiment, a method for mitigating an electromagnetic field includes positioning a mitigating coil around a linear alternator of linear motor so that the mitigating coil is coaxially located with an alternator coil; arranging the mitigating coil to generate a field to mitigate an electromagnetic field generated by the alternator coil; and passing an induced current from the alternator coil through the mitigating coil. | 07-21-2011 |
Tao Geng, New Bern, NC US
Patent application number | Description | Published |
---|---|---|
20120193337 | ELECTRIC OVEN WITH A HEATING ELEMENT REFLECTOR - An electric oven with a heating element designed to conduct broiling operations includes a reflector that is mounted between the heating element and a ceiling of a cooking cavity. The reflector can include reflecting portions that extend downward from side, rear or front edges of the reflector to help focus radiant energy produced by a heating element downward onto an underlying cooking surface. The reflector can also include a plurality of curved segments that are designed to reflect radiant energy emitted upward by the heating element back downward onto an underlying cooking surface. The curved segments can have varying focal lengths to help more evenly distribute the reflected radiant energy across the underlying cooking surface. | 08-02-2012 |
Wei Geng, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110025464 | Antenna Diversity For Wireless Tracking System And Method - The present invention provides a solution to determine a real-time location of an object in an indoor facility utilizing the spatial and angular antenna diversity on a sensor. Specifically, the spatial diversity is achieved by placing a second antenna a predetermined distance (which is greater than one-half of the wavelength) away from the first antenna. The angular diversity is obtained by placing the second antenna at ninety degrees (perpendicular) angle of the first antenna. | 02-03-2011 |
20120077514 | Wireless Tracking System And Method Utilizing Multiple Location Algorithms - The present invention provides a solution to mistaken location calculations based on multipath effects. The present invention determines a real-time location of an object in a facility using a combination of location algorithms, with a signal characteristic for a wireless signal from a communication device attached to the object received at a sensor of a mesh network. The location algorithms preferably include at least two of a proximity algorithm, a radial basis function algorithm, a maximum likelihood algorithm, a genetic algorithm, a minimum mean squared error algorithm, a radiofrequency fingerprinting algorithm, a multilateration algorithm, a time difference of arrival algorithm, a signal strength algorithm, a time of arrival algorithm, an angle of arrival algorithm, a spatial diversity algorithm, and a nearest neighbor algorithm | 03-29-2012 |
20140191897 | Low Frequency Magnetic Induction Positioning System And Method - A method and system for determining a real-time location of an object or person in a facility using low frequency magnetic induction positioning is disclosed herein. Each of the plurality of low frequency receivers is configured to receive a signal packet from a low-frequency magnetic induction transmitter, decode the signal packet, and estimate a distance from the low-frequency magnetic induction transmitter to the low-frequency receiver based on the decoded signal packet. | 07-10-2014 |
20140195256 | Workflow Context Aware Location Tracking System And Method - A system and method for improving tracking indoor or outdoor object movement using workflow context information. The system comprises a location tracking sub-system, communication devices and a context-aware location engine. The context-aware location engine is configured to receive from the location tracking sub-system a plurality of initial location estimations for the communication devices and generate a plurality of filtered location estimates for the communication devices. | 07-10-2014 |
20140195257 | Method And System For Workflow Modification - A system and method for workflow modification in a facility is disclosed herein. The system comprises a sensors, communication devices and a location engine. The location engine is configured to determine a location of at least one object or person, determine a first workflow from at least one location of the object or the person, and determine a departure from the first workflow. | 07-10-2014 |
Wei Geng, Hercules, CA US
Patent application number | Description | Published |
---|---|---|
20080268420 | Isolating Human Antibodies - The invention is drawn to a method of isolating human antibodies. | 10-30-2008 |
Xin Geng, Urbana, IL US
Patent application number | Description | Published |
---|---|---|
20080252392 | DISCRETE DITHERED FREQUENCY PULSE WIDTH MODULATION - A system is described for generating a discrete noise-shaped variable switching frequency signal that may be used to define a digital pulse width modulation (“PWM”) period. The system may define a switching frequency waveform that may be used to generate a current switching frequency signal as a function of a system clock. The system may quantize the current switching frequency signal to generate a discrete switching frequency signal that is realizable with the system clock. The system may detect quantization noise and input the noise into the current switching frequency signal to eliminate or reduce discrete tones at the switching frequencies of a PWM signal spectrum. | 10-16-2008 |
Xin Geng, Burlingame, CA US
Patent application number | Description | Published |
---|---|---|
20150232513 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B - The present invention provides compositions and methods for treating hepatitis B virus (HBV) infection as well as methods for identifying a compound or a composition that is suitable for treating HBV infection. In addition, the present invention provides a suitable non-mammalian animal model that can be used to screen for a compound or a composition that can inhibit HBV replication or treat HBV infection in a mammal. In particular, the present invention provides compositions and methods for treating hepatitis B infection by inhibiting interaction between HBV x protein and a Bcl-2 family protein or by reducing the expression level of a Bcl-2 family protein. | 08-20-2015 |
Xing Geng, Fort Wayne, IN US
Patent application number | Description | Published |
---|---|---|
20130253127 | TOUGHENING CROSS-LINKED THERMOSETS - Grafted triglycerides comprising an acrylated triglyceride grafted with a fatty acid residue containing 4 to 28 carbon atoms. Also described are methods for making a grafted triglyceride and for curing a material selected from vinyl esters and unsaturated polyesters and mixtures thereof and optionally a reactive diluent. The method includes the steps of mixing a grafted triglyceride of the present invention with a material selected from vinyl esters, unsaturated polyesters and mixtures thereof to form a mixture, and curing the mixture to form a cured resin system. A cured resin system comprising a cured product obtained by the foregoing method and composites containing the cured product and a filler or reinforcing material are also disclosed. This method also includes use of the grafted triglycerides to make toughened resin and composite systems with reduced hazardous air pollutants without significantly reducing the glass transition temperature and significantly increasing the viscosity. | 09-26-2013 |
20140316055 | TOUGHENING CROSS-LINKED THERMOSETS - Grafted triglycerides comprising an acrylated triglyceride grafted with a fatty acid residue containing 4 to 28 carbon atoms. Also described are methods for making a grafted triglyceride and for curing a material selected from vinyl esters and unsaturated polyesters and mixtures thereof and optionally a reactive diluent. The method includes the steps of mixing a grafted triglyceride of the present invention with a material selected from vinyl esters, unsaturated polyesters and mixtures thereof to form a mixture, and curing the mixture to form a cured resin system. A cured resin system comprising a cured product obtained by the foregoing method and composites containing the cured product and a filler or reinforcing material are also disclosed. This method also includes use of the grafted triglycerides to make toughened resin and composite systems with reduced hazardous air pollutants without significantly reducing the glass transition temperature and significantly increasing the viscosity. | 10-23-2014 |
20150361247 | TOUGHENING CROSS-LINKED THERMOSETS - Grafted triglycerides comprising an acrylated triglyceride grafted with a fatty acid residue containing 4 to 28 carbon atoms. Also described are methods for making a grafted triglyceride and for curing a material selected from vinyl esters and unsaturated polyesters and mixtures thereof and optionally a reactive diluent. The method includes the steps of mixing a grafted triglyceride of the present invention with a material selected from vinyl esters, unsaturated polyesters and mixtures thereof to form a mixture, and curing the mixture to form a cured resin system. A cured resin system comprising a cured product obtained by the foregoing method and composites containing the cured product and a filler or reinforcing material are also disclosed. This method also includes use of the grafted triglycerides to make toughened resin and composite systems with reduced hazardous air pollutants without significantly reducing the glass transition temperature and significantly increasing the viscosity. | 12-17-2015 |
Yan Geng, Langhorne, PA US
Patent application number | Description | Published |
---|---|---|
20090220614 | Thermo-Responsive Block Co-Polymers, and Use Thereof - Provided are thermo-responsive polymersomes, which display cold-controlled encapsulation near the physiological temperatures, and have a PDI less than 1.2. Morphology of the thermo-responsive polymersomes is a function of the weight fraction of the hydrophilic block in the block copolymer and the number average molecular weight (M | 09-03-2009 |
20100305201 | Method of Treating a Tumor and Biodistribution of a Drug Delivered by Worm-Like Filomicelles - Provided are filomicelle nanocarrier systems for the controlled transport and bioselective delivery of encapsulatable, cytotoxic active agents contained therein, particularly anticancer agents. Further provided are methods for controlling destabilization of the filomicelle membrane and the resulting hydrolysis-triggered, controlled release of the active agent(s) encapsulated therein by controlling the blend ratio (mol %) of hydrolysable PEO-block copolymer of the hydrophilic component(s) and of the more hydrophobic PEO-block copolymer component(s), wherein bioselective release of the encapsulated cytotoxic agents is distributed intracellularly, and wherein lowered dosage of the drug was delivered to the non-tumor organs. Thus, the filomicelle system offers enhanced tumor-selective biodistribution of a drug, and a reduced toxicity of the encapsulated drug to other organs. | 12-02-2010 |
Yan Geng, Athens, GA US
Yanfeng Geng, Billerica, MA US
Patent application number | Description | Published |
---|---|---|
20140149153 | METHOD AND SYSTEM FOR DYNAMIC PARKING ALLOCATION IN URBAN SETTINGS - A “smart parking” system and method for an urban environment based on a dynamic resource allocation approach. The system assigns and reserves an optimal resource (parking space) for a discrete user based on the user's objective function that combines proximity to destination with parking cost, while also ensuring that the overall parking capacity is efficiently utilized. The solution of each Mixed Integer Linear Program (MILP) is an optimal allocation based on current state information and subject to random events such as new user requests or parking spaces becoming available. | 05-29-2014 |
20140201121 | Method for Predicting Future Travel Time Using Geospatial Inference - Future travel times of a target vehicle traveling on a route from a starting point to a destination are predicted by first acquiring, by a probe vehicle, real-time probe data to alternative links from the starting point to the destination. Then, the future travel time for each link is predicted using a set of regression functions. | 07-17-2014 |
Ying Geng, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20150355401 | PATTERNED GLASS LIGHT GUIDE AND DISPLAY DEVICE COMPRISING THE SAME - Disclosed herein are glass light guides comprising a first surface, an opposing second surface, and at least one edge, wherein the first surface is patterned with a plurality of color converting elements, and wherein the second surface is optionally patterned with a plurality of light extraction features and/or color converting elements. Also disclosed herein are display devices comprising such glass light guides. The display devices may further comprise a thin-film transistor (TFT) having a coefficient of thermal expansion (CTE) substantially similar to the CTE of the glass light guide. | 12-10-2015 |
Ying Geng, Painted Post, NY US
Patent application number | Description | Published |
---|---|---|
20140126183 | IMMERSIVE DISPLAY WITH MINIMIZED IMAGE ARTIFACTS - Methods and apparatus provide for a display device comprising a plurality of display panels arranged adjacent to one another along the respective peripheral edges thereof, and wherein respective first and second viewing planes form an obtuse angle T relative to each other. The display device further includes a cover sheet located in proximity to, and covering the first and second viewing planes, and includes a light compensation portion located proximate to the peripheral edges of the first and second flat panel displays, and has a curvature complementary to the obtuse angle between the respective first and second viewing planes. The light compensation portion bends light produced by respective peripheral areas of the first and second flat panel displays proximate to the respective peripheral edges thereof to reduce visual discontinuities introduced by the peripheral edges into an image displayed on the first and second flat panel displays. | 05-08-2014 |
20150055948 | SYSTEMS AND METHODS FOR ALIGNING AN OPTICAL INTERFACE ASSEMBLY WITH AN INTEGRATED CIRCUIT - Systems and methods of aligning an optical interface assembly with an integrated circuit (IC) are disclosed. The method includes emitting light from an optical transmitter, passing the emitted light through the optical interface assembly in a first direction, and reflecting the emitted light from a reflective surface disposed immediately adjacent a front end of the optical interface assembly to define reflected light that travels back through the optical interface assembly in a second direction that is substantially opposite the first direction. The reflected light is received by an optical receiver that generates in response a receiver signal. The relative position of the optical interface assembly and the IC is adjusted to achieve an aligned position based on the receiver signal. The disclosure is also directed to a test plug for aligning an optical interface assembly to the IC. | 02-26-2015 |
20150198757 | VISUAL DISPLAY BACKLIGHT UNIT - A backlight unit suitable for use in illuminating a liquid crystal display panel of a display device. The backlight unit comprises a light guide plate, the light guide plate comprising a glass substrate with at least one edge, an intermediate waveguide physically and optically coupled to the at least one edge along a length of the edge, and a light source optically coupled to the intermediate waveguide | 07-16-2015 |
Yixuan Geng, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20150089334 | WORKBOOK COMPOSER - In various embodiments, methods, systems, and non-transitory computer-readable media are disclosed that allow users to specify runtime customizations of documents developed using a desktop integration framework. Workbook metadata is a set of information that describes how a given workbook is integrated with a particular web application. When a workbook is being published, metadata may be written into a local cache in the published workbook as well as a workbook definition file. Metadata management may be handed by a metadata service allowing updates and customization of published workbooks independently of a local cache in the published workbook and the workbook definition file. A workbook composer enables users to customize the metadata and store the customizations using the metadata manager. | 03-26-2015 |
20150089475 | RUNTIME CUSTOMIZATION INFRASTRUCTURE - In various embodiments, methods, systems, and non-transitory computer-readable media are disclosed that allow developers to allow runtime customizations of documents developed using a desktop integration framework. Workbook metadata is a set of information that describes how a given workbook is integrated with a particular web application. When a workbook is being published, metadata may be written into a local cache in the published workbook as well as a workbook definition file. Metadata management may be handed by a metadata service allowing updates and customization of published workbooks independently of a local cache in the published workbook and the workbook definition file. | 03-26-2015 |
Yong-Jian Geng, Pearland, TX US
Patent application number | Description | Published |
---|---|---|
20090210956 | COMPOSITION AND METHOD FOR CLUSTERIN-MEDIATED STEM CELL THERAPY FOR TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE - Methods and compositions are disclosed for inhibiting, deterring or preventing apoptosis of cardiac myocytes, transplanted stem cells, vascular stem cells, and vascular smooth muscle cells by means of expressing or synthesizing clusterin. Also disclosed are methods and compositions for producing recombinant clusterin, or its biologically active peptides, and for induction of clusterin-associated lipoproteins or enzymes for deterring or preventing inflammatory injury and apoptosis induced by oxLDL, oxysterols, cytokines, and Fas Ligand. Also disclosed is an induction method and composition for enhancing expression of ALDH and ALDH-associated enzymes or co-factors to prevent cytotoxicity or detoxification. Therapeutic methods providing new expression or overexpression of clusterin in vascular or cardiac tissue are expected to inhibit the formation of atherosclerotic lesions, stabilize existing atherosclerotic plaques, and repair failing or damaged cardiac tissue. | 08-20-2009 |
Yong-Jian Geng, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20080311607 | Methods and Compositions for Regulation of Stem Cell Survival, Proliferation, and Differentiation by Protein Ubiquitination - Compositions and methods for regulating in vitro cell growth are disclosed, and for providing undifferentiated stem cells or embryonic cells that are suitable for transplantation into damaged tissues or organs, or for use in tissue repair. A representative method includes causing the overexpression or underexpression of GalT binding protein (GtBP), also referred to as GalT associated protein (GTAP), in a cell such that ubiquitination of at least one cellular protein associated with cell adhesion and/or cell-to-cell interaction is correspondingly increased or decreased, causing inhibition of cell growth when GTAP is overexpressed and causing enhanced cell growth when GTAP is underexpressed by the cell. As a result, growth of the cell is altered or regulated. | 12-18-2008 |
20110171681 | METHODS AND COMPOSITIONS FOR REGULATION OF STEM CELL SURVIVAL, PROLIFERATION, AND DIFFERENTIATION BY PROTEIN UBIQUITINATION - Compositions and methods for regulating in vitro cell growth are disclosed, and for providing undifferentiated stem cells or embryonic cells that are suitable for transplantation into damaged tissues or organs, or for use in tissue repair. A representative method includes causing the overexpression or underexpression of GalT binding protein (GtBP), also referred to as GalT associated protein (GTAP), in a cell such that ubiquitination of at least one cellular protein associated with cell adhesion and/or cell-to-cell interaction is correspondingly increased or decreased, causing inhibition of cell growth when GTAP is overexpressed and causing enhanced cell growth when GTAP is underexpressed by the cell. As a result, growth of the cell is altered or regulated. | 07-14-2011 |
20140065112 | COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN - A major risk factor for ischemic heart disease is advanced age. In adult bone marrow and other tissues, the number and function of stem cells decline with aging. Telomerase reverse transcriptase (TERT) is a nuclear protein that decreases senescence. Myocardin (MYOCD) is a transcription factor for myogenesis. Thus a method is provided for the simultaneous delivery of the telomerase reverse transcriptase (TERT) and myocardin MYOCD genes that resuscitates mesenchymal stromal cells (MSCs) from aged adipose and bone marrow tissues by increasing their capacity for survival, proliferation, and differentiation. TERT | 03-06-2014 |
20150216800 | NEUROPROTECTIVE LIPOSOME COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE - Methods for the treatment of stroke, such as stroke of undetermined origin, by administration of xenon (Xe)-loaded liposome compositions are provided. In some aspects, Xe is encapsulated in echogenic liposomes and release of Xe can be enhanced by application of ultrasound stimulation. Compositions for use in treating stroke, such as liposomes loaded with Xe or Xe in combination with H2 or H2S, are also provided. | 08-06-2015 |
20160030470 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE - Provided herein is a novel composition for oral administration and delivery of Noble gas, such as xenon or argon. Methods of treating and preventing neuronal or cardiovascular damage with such compositions are also provided. The present invention relates generally to the fields of molecular biology, medicine and nutraceuticals. More particularly, it concerns methods for oral delivery of inert gas compositions, such as Xenon or Argon, for the treatment and prevention of disease. | 02-04-2016 |
Yue Geng, Wheeling, IL US
Patent application number | Description | Published |
---|---|---|
20150278823 | CLASSIFICATION OF DEVICE PROBLEMS OF CUSTOMER PREMISES DEVICES - A capability for classifying a device problem of a customer premises device of a customer is presented. The capability for classifying a device problem of a customer premises device of a customer may include receiving customer trouble ticket information of a trouble ticket associated with a customer, receiving customer device measurement information for a customer premises device of the customer, and classifying a device problem of the customer premises device based on text mining of the customer trouble ticket information and based on the customer device measurement information. | 10-01-2015 |
Yunpeng Geng, Northville, MI US
Patent application number | Description | Published |
---|---|---|
20130297142 | OIL LIFE MONITORING SYSTEM WITH FUEL QUALITY FACTOR - An oil-life monitoring system includes an engine revolution counter configured to provide an output corresponding to the rotation of a component of an engine, and a controller in communication with the engine revolution counter. The controller is configured to determine the composition/properties of a fuel being combusted by the engine, and select a fuel quality penalty factor from a table, with the fuel quality penalty factor corresponding to the determined composition/properties of the fuel. Additionally, the controller is configured to compute an adjusted revolution count by multiplying the rotations of the component of the engine by the fuel quality penalty factor, and aggregate the adjusted revolution count. | 11-07-2013 |
20140039777 | FUEL QUALITY MONITORING SYSTEM - A fuel quality monitoring system includes a fuel composition sensor configured to provide an indication of a composition of a liquid fuel within a fuel tank, and a controller. The controller is configured to receive the indication of the monitored fuel composition from the fuel composition sensor; detect an amount of an impurity from the received indication; and compare the amount of the impurity to a threshold. If the amount of the impurity exceeds the threshold, the controller is configured to adjust an operating parameter of an engine to account for the detected impurity. When the amount of the impurity exceeds a threshold which makes engine combustion unmanageable, the fuel is restricted from entering the engine or fuel tank. | 02-06-2014 |
Zhaohui Geng, New Brighton, MN US
Patent application number | Description | Published |
---|---|---|
20130243735 | PRODUCTION OF INSULIN PRODUCING CELLS - The invention provides methods for differentiating stem cells along the pancreatic lineage as well as large scale culture methods. The present invention further provides pancreatic progenitor cells derived from stem cells to provide pancreatic cells to a subject. | 09-19-2013 |
20150322407 | PRODUCTION OF INSULIN PRODUCING CELLS - The invention provides methods for differentiating stem cells along the pancreatic lineage as well as large scale culture methods. The present invention further provides pancreatic progenitor cells derived from stem cells to provide pancreatic cells to a subject. | 11-12-2015 |
Zheng Jason Geng, Vienna, VA US
Patent application number | Description | Published |
---|---|---|
20160128553 | Intra- Abdominal Lightfield 3D Endoscope and Method of Making the Same - The inventions disclosed herein are related to various designs of intra-abdominal three-dimensional (3D) imaging systems that are able to provide 3D visualization, measurement, registration and display capability for minimally invasive surgeries. | 05-12-2016 |
Zheng Jason Geng, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20090010507 | SYSTEM AND METHOD FOR GENERATING A 3D MODEL OF ANATOMICAL STRUCTURE USING A PLURALITY OF 2D IMAGES - A system and method are provided for generating a three dimensional (3D) model of an anatomical structure of a patient using a plurality of two dimensional (2D) images acquired using a camera. The method includes the operation of searching the plurality of 2D images to detect correspondence points of image features across at least two images. Camera motion parameters can be determined using the correspondence points for a sequence of at least two images taken at different locations by the camera moving within the internal anatomical structure. A further operation is computing dense stereo maps for 2D image pairs that are temporally adjacent. A consistent 3D model can be formed by fusing together multiple 2D images which are applied to a plurality of integrated 3D model segments. Then the 3D model of the patient's internal anatomical structure can be displayed to a user on a display device. | 01-08-2009 |
20100020254 | MULTI-PANEL VIRTUAL IMAGE DISPLAY - A multiple panel system and method for displaying a virtual image viewable from multiple viewing angles is provided. Reflective viewing panels are arranged relative to one another in at least a partially closed enclosure arrangement. A display screen is oriented with respect to the viewing panels such that an image displayed on the display screen creates a virtual image viewable from multiple angles. An image formation mechanism is operable to display an image onto the display screen. | 01-28-2010 |
Zhixian Geng, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20140343415 | Diagnosis of Swallowing Disorders Using High Resolution Manometry - Parameters extracted from high definition manometric measurements of the pharynx and upper esophagus at preidentified locations and times are applied to a supervised learning machine trained using x-ray fluoroscopy data to provide diagnostic information comparable to that of x-ray fluoroscopy without radiation exposure. | 11-20-2014 |